Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes

Stopped early · Not applicable

Conditions studied: Type1diabetes

In brief

To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques, to increase CGM use among publicly-insured youth with type 1 diabetes (T1D).

Key facts

Study ID

NCT03297762

Run by

Stanford University

People needed

4

Starts

2018-05-07

Expected to finish

2019-06-01

Last updated by the study team

2020-04-20

Who can join

Age: 13 and older, up to 19. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• type 1 diabetes for more than 6 months
• on insulin pump or multiple daily injections without plans to change modality in next 6 months
• insured by CCS or Medi-Cal
• receiving care at Lucile Packard Children's Hospital or Stanford Children's Health outpatient clinics
• English or Spanish-speaking

You may not qualify if…

• major illness or condition that may alter glucose control or ability to complete the study including pregnancy, cystic fibrosis, cancer, liver disease, history of transplant, or hemoglobinopathy
• current oral glucocorticoid use
• prior use of a CGM system
• hemoglobin A1C <7.5% or >12%
• no wireless internet access

Where it is running

• Stanford Children's — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.